31 related articles for article (PubMed ID: 25805163)
1. Monitoring treatments with unfractionated heparin: CTAD must be used instead of citrate as the anticoagulant solution when using partial-draw collection tubes. Results of a multicenter evaluation.
Toulon P; Abecassis L; Smahi M; Ternisien C
Thromb Res; 2010 Dec; 126(6):536-42. PubMed ID: 20950840
[TBL] [Abstract][Full Text] [Related]
2. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
Ray PK; Harper TA
J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
[No Abstract] [Full Text] [Related]
3. [New oral anticoagulants - influence on coagulation tests].
Simeon L; Nagler M; Wuillemin WA
Dtsch Med Wochenschr; 2014 Jan; 139(3):94-9. PubMed ID: 24399657
[TBL] [Abstract][Full Text] [Related]
4. Use of an automated coagulation analyzer to perform heparin neutralization with polybrene in blood samples for routine coagulation testing: practical, rapid, and inexpensive.
Tientadakul P; Kongkan C; Chinswangwatanakul W
Arch Pathol Lab Med; 2013 Nov; 137(11):1641-7. PubMed ID: 24168503
[TBL] [Abstract][Full Text] [Related]
5. Monitoring unfractionated heparin with APTT: a French collaborative study comparing sensitivity to heparin of 15 APTT reagents.
Gouin-Thibaut I; Martin-Toutain I; Peynaud-Debayle E; Marion S; Napol P; Alhenc-Gelas M;
Thromb Res; 2012 May; 129(5):666-7. PubMed ID: 22169771
[No Abstract] [Full Text] [Related]
6. Ex vivo neutralization of unfractionated heparin for assessing overall haemostatic potential in patient plasma.
Božič-Mijovski M; Vučnik M; Boc V; Blinc A; Stegnar M
Thromb Res; 2015 May; 135(5):1042-4. PubMed ID: 25805163
[No Abstract] [Full Text] [Related]
7. [Heparin in therapeutics (author's transl)].
Capel P
Rev Med Brux; 1981 Mar; 2(3):181-9. PubMed ID: 7015442
[No Abstract] [Full Text] [Related]
8. [Advances in the laboratory diagnosis of disorders of hemostasis].
Sawicka B
Pol Tyg Lek; 1985 Jul; 40(28):806-9. PubMed ID: 3903694
[No Abstract] [Full Text] [Related]
9. [Monitoring of heparin therapy during extracorporeal bypass: what are the remaining questions?].
Jude B; Lasne D; Mouton C; de Moerloose P; ; ;
Ann Fr Anesth Reanim; 2004 Jun; 23(6):589-96. PubMed ID: 15234724
[TBL] [Abstract][Full Text] [Related]
10. [Anticoagulation in pregnancy and post partum in heat valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism].
Gohlke-Bärwolf C
Z Kardiol; 2001; 90 Suppl 4():49-56. PubMed ID: 11373944
[TBL] [Abstract][Full Text] [Related]
11. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
Olson JD; Arkin CF; Brandt JT; Cunningham MT; Giles A; Koepke JA; Witte DL
Arch Pathol Lab Med; 1998 Sep; 122(9):782-98. PubMed ID: 9740136
[TBL] [Abstract][Full Text] [Related]
12. Problems and solutions for testing hemostasis assays while patients are on anticoagulants.
Tripodi A
Semin Thromb Hemost; 2012 Sep; 38(6):586-92. PubMed ID: 22718257
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
